Reaction
Covid-19 Immunisation reporting signals
As of the last recalculation, Covid-19 Immunisation appears in 835 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CERTOLIZUMAB PEGOL (PRR 205.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Certolizumab Pegol | 449 | 205.4 | 206.2 |
| Human Immunoglobulin G | 42 | 53.4 | 53.5 |
| Brivaracetam | 11 | 30.9 | 30.9 |
| Lacosamide | 35 | 24.4 | 24.4 |
| Ixazomib | 26 | 23.2 | 23.2 |
| Terazosin Hydrochloride | 6 | 16.9 | 16.9 |
| Rotigotine | 7 | 12.2 | 12.2 |
| Umeclidinium | 4 | 11.2 | 11.2 |
| Bimekizumab | 4 | 4.7 | 4.7 |
| Guselkumab | 5 | 3.5 | 3.5 |